Results 161 to 170 of about 17,275 (222)

Detection of vaccine-derived poliovirus type 2 amid the burden of infectious diseases in the UK: A cause for alarm. [PDF]

Ann Med Surg (Lond), 2022
Kamran A, Salman M, Siddiqui R, Shabbir NZ, Rohail S, Sukaina M.   +5 more
europepmc   +1 more source

Monitoring the Risk of Type-2 Circulating Vaccine-Derived Poliovirus Emergence during Roll-Out of Type-2 Novel Oral Polio Vaccine [PDF]

Vaccines (Basel)
Peak CM, Lyons H, Voorman A, Gray EJ, Cooper LV, Blake IM, Hawes K, Bandyopadhyay AS.   +7 more
europepmc   +2 more sources

Assessing country compliance with circulating vaccine-derived poliovirus type 2 outbreak response standard operating procedures: April 2016 to December 2020. [PDF]

Vaccine, 2023
Darwar R, Biya O, Greene SA, Jorba J, Al Safadi M, Franka R, Wiesen E, Durry E, Pallansch MA.   +8 more
europepmc   +1 more source

A vaccine derived poliovirus case in an immunocompromised argentinian child [PDF]

International Journal of Infectious Diseases, 2010
Burgos, M.E., Elkik, S., Barbosa, P., Oleastro, M., Freire, C., Parra, A., Caparelli, M., Sarkis, C.   +7 more
openaire   +1 more source

Outbreak Response to Circulating Vaccine-Derived Poliovirus in Three Northern Regions of Ghana, 2019. [PDF]

Biomed Res Int
Odoom JK, Dzotse EK, Nii-Trebi NI, Opare D, Akyereko E, Attiku K, Duker EO, Eshun M, Boahene BB, Gberbi E, Houphouet EE, Diamenu S, Adjabeng M, Asamoah-Frimpong J, Ameme D, Opare JKL, Obodai E.   +16 more
europepmc   +1 more source

Detection of a Highly Divergent Type 3 Vaccine-Derived Poliovirus in a Child with a Severe Primary Immunodeficiency Disorder - Chongqing, China, 2022. [PDF]

MMWR Morb Mortal Wkly Rep, 2022
Yao N, Liu Y, Xu JW, Wang Q, Yin ZD, Wen N, Yang H, Rodewald LE, Zhang ZY.   +8 more
europepmc   +1 more source

On the molecular mechanisms of konzo and neurolathyrism [PDF]

, 2011
Diasolua Ngudi, Delphin, Kuo, Yu-Haey, Lambein, Fernand, Van Moorhem, Marijke   +3 more
core   +1 more source

Analysis of vaccination campaign effectiveness and population immunity to support and sustain polio elimination in Nigeria [PDF]

, 2016

core   +1 more source

Antisera-Neutralizing Capacity of a Highly Evolved Type 2 Vaccine-Derived Poliovirus from an Immunodeficient Patient. [PDF]

Viruses
Wu Y, Zhang R, Yuan G, He L, Dai X, Chuan H, Wang M, Liu J, Xu L, Liao G, Li W, Zhou J.   +11 more
europepmc   +1 more source

A national cross-sectional study for poliovirus seroprevalence in the Republic of Korea in 2012: implication for deficiency in immunity to polio among middle-aged people [PDF]

, 2015
Geun-Ryang Bae, Hye-Jin Kim, Ji-Yeon Hyeon, Kwangsook Park, Sang Won Lee, Seoyeon Hwang, Somin Lee, Yong-Seok Jeong, Young Joon Park, Yunhyung Kwon   +9 more
core   +1 more source